-----Mensagem original-----
De: Mario F. de Camargo Maranhão [mailto:mariomaranhao@uol.com.br]
Enviada em: quinta-feira, 31 de março de 2005 13:33
Para: aloyzio.achutti
Assunto: - 31 de março - PRORROGADO! prazo para inscrições com taxa reduzida para Latino-americanos
Achutti: o valor REDUZIDO da inscrição para brasileiros e latino americanos está prolongado indefinidamente.
Gratos,
MM
Endereço para inscrições:
https://www.ics-online.com/ei/getdemo.ei?id=125&s=_1G80YNLJ0
This Blog AMICOR is a communication instrument of a group of friends primarily interested in health promotion, with a focus on cardiovascular diseases prevention. To contact send a message to achutti@gmail.com http://achutti.blogspot.com
Translate AMICOR contents if you like
Thursday, March 31, 2005
Cardiologia Baseada em Evidência
cardiologia.pdf (application/pdf Object)
: Robespierre ... [mailto:dr.robespierre@gmail.com]
Enviada em: quinta-feira, 31 de março de 2005 14:13
Para: aloyzio.achutti@terra.com.br
Assunto: Artigo ATS - Robespierre
Já se encontra disponível no site da Sociedade Mineira de Cardiologia o artigo sobre Medicina Baseada em Evidências,
Atenciosamente,
Robespierre
Wednesday, March 30, 2005
6th ICPC 31 de março - Prazo Inscrições US$110 para Latino-Americanos
Aproxima-se a 6a. Conferência Internaciconal de Cardiologia Preventiva em Foz do Iguaçu. Dia 31 de março termina o prazo para as inscrições com taxa reduzida para Latino-americanos.
Aproveitem clicando no hyperlink ou pelo endereço abaixo:
https://www.ics-online.com/ei/getdemo.ei?id=125&s=_1G80YNLJ0
ou em caso de algum problema comunicando-se com
Aproveitem clicando no hyperlink ou pelo endereço abaixo:
https://www.ics-online.com/ei/getdemo.ei?id=125&s=_1G80YNLJ0
ou em caso de algum problema comunicando-se com
Paula Buczak
Project Manager
ICS Congresos Internacionales S.A.
P.O. BOX 73
C1084ZAA - Buenos Aires, Argentina
Tel +54-11-4382-5772
Fax +54-11-4382-5730
www.congresosint.com.ar
INCON Partner
ICS - The Netherlands
www.lgce.nl
ICS - Denmark
www.ics.dk
CMC Ltda - Chile
www.cmcevent.com
WEBSIMPOSIO
Foi feita ontem, dia 29 de março, a primeira transmissão ao vivo do WebSimpósio, com o tema Atualização do Congresso American College of Cardiology e participação ativa da platéia de 201 colegas de todo o Brasil.
Mesmo não tendo participado do programa ao vivo, você poderá agora assistir ao conteúdo, no momento em que desejar, rigorosamente com a mesma qualidade da transmissão ao vivo. Você poderá, inclusive, assistir como os palestrantes responderam às perguntas formuladas pelos colegas de todo o Brasil.
Estamos empenhados em fazer um excelente programa e agradecemos seu apoio, esperando contar com você, nos futuros eventos.
Equipe WebSimpósio
congressos@websimposio.com.br
www.websimposio.com.br
Mesmo não tendo participado do programa ao vivo, você poderá agora assistir ao conteúdo, no momento em que desejar, rigorosamente com a mesma qualidade da transmissão ao vivo. Você poderá, inclusive, assistir como os palestrantes responderam às perguntas formuladas pelos colegas de todo o Brasil.
Estamos empenhados em fazer um excelente programa e agradecemos seu apoio, esperando contar com você, nos futuros eventos.
Equipe WebSimpósio
congressos@websimposio.com.br
www.websimposio.com.br
Becoming the Framingham Study 1947-1950 -- Oppenheimer 95 (4): 602 -- American Journal of Public Health
Becoming the Framingham Study 1947-1950 -- Oppenheimer 95 (4): 602 -- American Journal of Public Health: "Becoming the Framingham Study 1947�1950
Gerald M. Oppenheimer, PhD, MPH
In the epidemiological imagination, the Framingham Heart Study has attained iconic status, both as the prototype of the cohort study and as a result of its scientific success.
When the Public Health Service launched the study in 1947, epidemiological knowledge of coronary heart disease was poor, and epidemiology primarily involved the study of infectious disease. In constructing their investigation, Framingham�s initiators had to invent new approaches to epidemiological research. These scientific goals were heavily influenced by the contending institutional and personal interests buffeting the study.
The study passed through vicissitudes and stages during its earliest years as its organizers grappled to define its relationship to medicine, epidemiology, and the local community. "
Gerald M. Oppenheimer, PhD, MPH
In the epidemiological imagination, the Framingham Heart Study has attained iconic status, both as the prototype of the cohort study and as a result of its scientific success.
When the Public Health Service launched the study in 1947, epidemiological knowledge of coronary heart disease was poor, and epidemiology primarily involved the study of infectious disease. In constructing their investigation, Framingham�s initiators had to invent new approaches to epidemiological research. These scientific goals were heavily influenced by the contending institutional and personal interests buffeting the study.
The study passed through vicissitudes and stages during its earliest years as its organizers grappled to define its relationship to medicine, epidemiology, and the local community. "
Tuesday, March 29, 2005
Endothelial Dysfunction in Childhood Infection
Marietta Charakida MD*, et al.
Background--Atherosclerosis begins in early life, and endothelial dysfunction is recognized as a key initiating event in the development of atherosclerosis. Although infection has been implicated in endothelial dysfunction and atherogenesis, the impact of acute common childhood infections on the vascular endothelium is unknown.
Methods and Results--We studied 600 children aged 10 years drawn from the Avon Longitudinal Study of Parents and Children. The children were divided into 3 groups: those with current acute infection (AI; n=135; 73 boys and 62 girls); a convalescent group with infection in the past 2 weeks (n=166; 78 boys and 88 girls), and a healthy control group (n=299; 131 boys and 168 girls). Endothelial function was determined in all subjects by high-resolution ultrasound to measure brachial artery flow-mediated dilation (FMD) and was expressed as the percentage change in diameter from baseline after reactive hyperemia. FMD was repeated in 40 children in the AI group and 50 in the control group after a mean interval of 1 year. FMD was lower in both the AI group (6.3±2.7%, mean±SD) and the convalescent group (8.1±3.1%) than in the control group (9.7±2.5%; P<0.001 for both). The observed differences in FMD remained after adjustment for potential confounding variables. At the repeat visit, FMD was unchanged in controls (P=0.85) but improved in the AI group (P<0.001).
Conclusions--Acute infection in childhood is associated with impaired endothelium-dependent vasodilation. These findings support a potential role for previously unsuspected extrinsic inflammatory stimuli in the pathogenesis of early atherosclerosis.
Background--Atherosclerosis begins in early life, and endothelial dysfunction is recognized as a key initiating event in the development of atherosclerosis. Although infection has been implicated in endothelial dysfunction and atherogenesis, the impact of acute common childhood infections on the vascular endothelium is unknown.
Methods and Results--We studied 600 children aged 10 years drawn from the Avon Longitudinal Study of Parents and Children. The children were divided into 3 groups: those with current acute infection (AI; n=135; 73 boys and 62 girls); a convalescent group with infection in the past 2 weeks (n=166; 78 boys and 88 girls), and a healthy control group (n=299; 131 boys and 168 girls). Endothelial function was determined in all subjects by high-resolution ultrasound to measure brachial artery flow-mediated dilation (FMD) and was expressed as the percentage change in diameter from baseline after reactive hyperemia. FMD was repeated in 40 children in the AI group and 50 in the control group after a mean interval of 1 year. FMD was lower in both the AI group (6.3±2.7%, mean±SD) and the convalescent group (8.1±3.1%) than in the control group (9.7±2.5%; P<0.001 for both). The observed differences in FMD remained after adjustment for potential confounding variables. At the repeat visit, FMD was unchanged in controls (P=0.85) but improved in the AI group (P<0.001).
Conclusions--Acute infection in childhood is associated with impaired endothelium-dependent vasodilation. These findings support a potential role for previously unsuspected extrinsic inflammatory stimuli in the pathogenesis of early atherosclerosis.
Uric Acid and the Heart
PLoS Medicine: Uric Acid and the Heart
Wheeler JG, Juzwishin KDM, Eiriksdottir G, Gudnason V, Danesh J (2005) Serum uric acid and coronary heart disease in 9,458 incident cases and 155,084 controls: Prospective study and meta-analysis.
What is the level of medical evidence that should be used to inform medical practice? At the bottom of the hierarchy of evidence are anecdotes, expert opinion, case reports, and case series, and at the top is the systematic review of published (and sometimes unpublished) evidence. By necessity, systematic reviews come many years after hypotheses are first raised, and in the interim recommendations for practice may sway back and forth. One example of this is the debate over the role of uric acid in heart disease, which has been going on for more than 50 years. It started with a paper published in 1951 in the Annals of Internal Medicine that found higher serum uric acid concentrations in patients with coronary heart disease (CHD) compared with controls. Since then, measurement of serum uric acid has been suggested as a predictor of CHD. But many of the studies on serum uric acid are epidemiologic studies—somewhere in the middle of the hierarchy of evidence—and have come to different conclusions about how useful measurement of uric acid is.
Wheeler JG, Juzwishin KDM, Eiriksdottir G, Gudnason V, Danesh J (2005) Serum uric acid and coronary heart disease in 9,458 incident cases and 155,084 controls: Prospective study and meta-analysis.
What is the level of medical evidence that should be used to inform medical practice? At the bottom of the hierarchy of evidence are anecdotes, expert opinion, case reports, and case series, and at the top is the systematic review of published (and sometimes unpublished) evidence. By necessity, systematic reviews come many years after hypotheses are first raised, and in the interim recommendations for practice may sway back and forth. One example of this is the debate over the role of uric acid in heart disease, which has been going on for more than 50 years. It started with a paper published in 1951 in the Annals of Internal Medicine that found higher serum uric acid concentrations in patients with coronary heart disease (CHD) compared with controls. Since then, measurement of serum uric acid has been suggested as a predictor of CHD. But many of the studies on serum uric acid are epidemiologic studies—somewhere in the middle of the hierarchy of evidence—and have come to different conclusions about how useful measurement of uric acid is.
Sunday, March 27, 2005
Prevalence of Risk Factors for Cardiovascular Disease in Employees of the Research Center at Petrobras
Maria de Fátima Duarte Matos, Nelson Albuquerque Souza e Silva,Armando Jorge Marques Pimenta, Antonio José Ledo Alves da Cunha
Results - Of 1,911 employees, 970 were studied, 75.4% were men and 24.6% were women with a mean age of 42.2 years old. The risk factors were lack of exercise (67.3%), cholesterol > 200 mg/dL (56.6%), overweight (42%), obesity (17%), blood hypertension (18.2%), smoking (12.4%), and diabetes mellitus (2.5%).
Conclusion - The high prevalence of risk factors for cardiovascular disease in young individuals draws attention to the need for the adoption of workplace programs to encourage healthy lifestyles and to prevent diseases.
Variability Among Cardiologists in the Management of Patients Under Secondary Prevention of Ischemic Heart Disease
Variability Among Cardiologists in the Management of Patients Under Secondary Prevention of Ischemic Heart Disease
Ricardo Stein, Caroline Alboim, Candice Campos, Renato Bandeira de Mello, Guido Aranha Rosito, Carisi Anne Polanczyk
disease, prevalence of previous myocardial infarction, and previous revascularization procedures showed no significant differences between the patients in groups I and II. In group I, 98% of the patients received aspirin, while, in group II, 83% of the patients received that drug (p=0.02). In regard to the use of lipid-lowering drugs, the prevalences were 60% in group I and 19% in group II (p=0.001). The lipid profile examination was
requested for 98% of group I individuals and 79% of group II individuals (p=0.003).
Conclusion
In regard to new medical evidence, mainly prescription of aspirin and lipid-lowering drugs, the management was more reliable in the outpatient clinic specifically aimed at treating ischemic heart disease.
Indicadores de Doença Cardiovascular no Estado do Rio de Janeiro com Relevo para a Insuficiência Cardíaca
Indicadores de Doença Cardiovascular no Estado do Rio de Janeiro com Relevo para a Insuficiência Cardíaca
Francisco Manes Albanesi Filho
As doenças cardiovasculares (DCV) constituem a segunda causa de hospitalização pelo Sistema Único de Saúde (SUS) no Estado do Rio de Janeiro. Entre elas, a síndrome de insuficiência cardíaca (IC) é a mais freqüente. Os dados apresentados neste artigo revelam a incidência das internações e óbitos, a taxa de mortalidade e os recursos financeiros empregados no país e no Estado do Rio de Janeiro para o atendimento desses pacientes. A IC constitui atualmente o maior desafio clínico na área da saúde pública, sendo considerado um problema epidêmico em progressão.
Reflexões sobre o Relacionamento entre o Médico Acadêmico, a Sociedade em Geral e Empresas Produtoras de Medicamentos e Equipamentos
Clinical and Demographic Characteristics of 99 Episodes of Rheumatic Fever in Acre, the Brazilian Amazon
Clinical and Demographic Characteristics of 99 Episodes of Rheumatic Fever in Acre, the Brazilian Amazon
Fátima Borges, Maria Luiza A. Barbosa, Renata Beyruth Borges, Olívia C. Pinheiro, Carlos Cardoso, Claudilson Bastos, Roque Aras Rio Branco, AC / Salvador, BA
From July 2003 to February 2004, 99 patients with rheumatic fever were assessed (mean age, 11 years, SD= ± 10.18) with a predominance of females (59.6%), and a racial phenotype of a mixture of Caucasian and Indian (60.6%). Three individuals were excluded because they did not meet the diagnostic criteria. Mean age was 9.1 years old, and in 30.4% of the patients, the disease was diagnosed at the first episode of rheumatic fever.
The most frequent clinical manifestations were carditis (69.7%), arthritis (21.4%), and chorea (6.1%). Mitral regurgitation was the most common lesion (36.4%) followed by the association of mitral regurgitation and aortic regurgitation (9.1%).
Conclusion
Rheumatic carditis was the most common manifestation of rheumatic fever, predominant in the group with a racial mixture of Caucasian and Indian (60.6%). Low compliance with antibiotic therapy contributed to the recurrence of the disease and to cardiac sequelae.
Saturday, March 26, 2005
4o.Congresso Internacional de Cardiologia pela INTERNET
De: Silvia Nanfara [mailto:nanfara@fac.org.ar]
Enviada em: sábado, 26 de março de 2005 18:34
Assunto: Cuarto Congreso Virtual de Cardiologia
Cuarto Congreso Virtual de Cardiologia, organizado por la Region Patagonica de la Federacion Argentina de Cardiologia a realizarse entre el 01 de setiembre y el 30 de noviembre de 2005.
Como en las ediciones anteriores la inscripcion es gratuita.
Aprovecho la oportunidad para invitarlo aparticipar activamante del mismo.
Le agradezco su atencion y lo saludo atentamente.
Dra. Silvisa Nanfara
4to Congreso Internacional de Cardiología por Internet
4to Congreso Virtual de Cardiología - CCVC
Esta cuarta edición de la mayor actividad cardiológica en Internet se desarrollará entre el 1 de septiembre y el 30 de noviembre de 2005 en www.fac.org.ar/ccvc
Desde el 1ero de marzo hasta el 30 de mayo de 2005, se reciben abstracts de temas libres para ser presentados en el CCVC. Se accede a las instrucciones para la preparacion y el envio desde www.fac.org.ar/ccvc/gralesp/instrtl.htm
La asistencia y la participación en el CCVC son gratuitas. La inscripción se realiza llenando un formulario en www.fac.org.ar/ccvc/gralesp/inscesp.php3
Encontrarán mayores informaciones sobre el congreso en www.fac.org.ar/ccvc
Prof. Dra. Silvia Fedchteyn de Eskenazi
CETIFAC
sidemi@terra.com.pe
Cuarto Congreso Virtual de Cardiologia
Federacion Argentina de Cardiologia
Enviada em: sábado, 26 de março de 2005 18:34
Assunto: Cuarto Congreso Virtual de Cardiologia
Cuarto Congreso Virtual de Cardiologia, organizado por la Region Patagonica de la Federacion Argentina de Cardiologia a realizarse entre el 01 de setiembre y el 30 de noviembre de 2005.
Como en las ediciones anteriores la inscripcion es gratuita.
Aprovecho la oportunidad para invitarlo aparticipar activamante del mismo.
Le agradezco su atencion y lo saludo atentamente.
Dra. Silvisa Nanfara
4to Congreso Internacional de Cardiología por Internet
4to Congreso Virtual de Cardiología - CCVC
Esta cuarta edición de la mayor actividad cardiológica en Internet se desarrollará entre el 1 de septiembre y el 30 de noviembre de 2005 en www.fac.org.ar/ccvc
Desde el 1ero de marzo hasta el 30 de mayo de 2005, se reciben abstracts de temas libres para ser presentados en el CCVC. Se accede a las instrucciones para la preparacion y el envio desde www.fac.org.ar/ccvc/gralesp/instrtl.htm
La asistencia y la participación en el CCVC son gratuitas. La inscripción se realiza llenando un formulario en www.fac.org.ar/ccvc/gralesp/inscesp.php3
Encontrarán mayores informaciones sobre el congreso en www.fac.org.ar/ccvc
Prof. Dra. Silvia Fedchteyn de Eskenazi
CETIFAC
sidemi@terra.com.pe
Cuarto Congreso Virtual de Cardiologia
Federacion Argentina de Cardiologia
Epidemiology and reporting of randomised trials published in PubMed Journals.
The Journal : Current Issue
An-Wen Chan, Douglas G Altman
Although randomised trials are important for evidence-based medicine, little is known about their overall characteristics. We assessed the epidemiology and reporting of methodological details for all 519 PubMed-indexed randomised trials published in December, 2000 (383 [74%] parallel-group, 116 [22%] crossover). 482 (93%) were published in specialty journals. A median of 80 participants (10th-90th percentile 25-369) were recruited for parallel-group trials. 309 (60%) were blinded. Power calculation, primary outcomes, random sequence generation, allocation concealment, and handling of attrition were each adequately described in less than half of publications. The small sample sizes are worrying, and poor reporting of methodological characteristics will prevent reliable quality assessment of many published trials.
An-Wen Chan, Douglas G Altman
Although randomised trials are important for evidence-based medicine, little is known about their overall characteristics. We assessed the epidemiology and reporting of methodological details for all 519 PubMed-indexed randomised trials published in December, 2000 (383 [74%] parallel-group, 116 [22%] crossover). 482 (93%) were published in specialty journals. A median of 80 participants (10th-90th percentile 25-369) were recruited for parallel-group trials. 309 (60%) were blinded. Power calculation, primary outcomes, random sequence generation, allocation concealment, and handling of attrition were each adequately described in less than half of publications. The small sample sizes are worrying, and poor reporting of methodological characteristics will prevent reliable quality assessment of many published trials.
Friday, March 25, 2005
EPIDEMIOLOGY: How Dirty Air Hurts the Heart -- Kaiser 307 (5717): 1858b -- Science
EPIDEMIOLOGY: How Dirty Air Hurts the Heart -- Kaiser 307 (5717): 1858b -- Science
. Citing the body of evidence, an American Heart Association scientific panel in last June labeled fine particles a "serious public health problem" and urged the Environmental Protection Agency to consider "even more stringent standards."
. Citing the body of evidence, an American Heart Association scientific panel in last June labeled fine particles a "serious public health problem" and urged the Environmental Protection Agency to consider "even more stringent standards."
Leucocyte count may predict heart disease in women -- Kermode-Scott 330 (7493): 690 -- BMJ
Leucocyte count may predict heart disease in women -- Kermode-Scott 330 (7493): 690 -- BMJ
“The white blood cell count comes out at least as strong a predictor of coronary heart disease as the C reactive protein,” said Dr Margolis. “In any situation in which you might consider testing C reactive protein to further evaluate cardiovascular risk, then the white blood cell count could be considered as an alternative.”
“The white blood cell count comes out at least as strong a predictor of coronary heart disease as the C reactive protein,” said Dr Margolis. “In any situation in which you might consider testing C reactive protein to further evaluate cardiovascular risk, then the white blood cell count could be considered as an alternative.”
New standards for cardiopulmonary resuscitation -- Deakin 330 (7493): 685 -- BMJ
New standards for cardiopulmonary resuscitation -- Deakin 330 (7493): 685 -- BMJ: "Charles D Deakin, consultant anaesthetist "
New standards for cardiopulmonary resuscitation
New standards for cardiopulmonary resuscitation -- Deakin 330 (7493): 685 -- BMJ
Represent a milestone in resuscitation practice and training
Charles D Deakin, consultant anaesthetist
A joint statement, Cardiopulmonary Resuscitation—Standards for Clinical Practice and Training, has been issued by the Royal College of Anaesthetists, Royal College of Physicians of London, the Intensive Care Society, and the Resuscitation Council (UK).1 This was endorsed by a further nine healthcare organisations including the National Patient Safety Agency and defines minimum standards for the delivery of resuscitation related services in healthcare institutions. Perhaps the only major omissions from this list are the Royal College of General Practitioners and the Royal College of Obstetricians.
Represent a milestone in resuscitation practice and training
Charles D Deakin, consultant anaesthetist
A joint statement, Cardiopulmonary Resuscitation—Standards for Clinical Practice and Training, has been issued by the Royal College of Anaesthetists, Royal College of Physicians of London, the Intensive Care Society, and the Resuscitation Council (UK).1 This was endorsed by a further nine healthcare organisations including the National Patient Safety Agency and defines minimum standards for the delivery of resuscitation related services in healthcare institutions. Perhaps the only major omissions from this list are the Royal College of General Practitioners and the Royal College of Obstetricians.
Thursday, March 24, 2005
Atualização de Congressos Internacionais de Cardiologia
::: WEBSIMPÓSIO :::
Gratuito, mas é preciso inscrever-se
Gratuito, mas é preciso inscrever-se
Subscribe to:
Posts (Atom)